AU2877800A - Short contact treatment of psoriasis with topical retinoids - Google Patents

Short contact treatment of psoriasis with topical retinoids

Info

Publication number
AU2877800A
AU2877800A AU28778/00A AU2877800A AU2877800A AU 2877800 A AU2877800 A AU 2877800A AU 28778/00 A AU28778/00 A AU 28778/00A AU 2877800 A AU2877800 A AU 2877800A AU 2877800 A AU2877800 A AU 2877800A
Authority
AU
Australia
Prior art keywords
psoriasis
contact treatment
short contact
topical retinoids
retinoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28778/00A
Inventor
Susan Bershad
Mark G. Lebwohl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MARK G LEBWOHL
Original Assignee
MARK G LEBWOHL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/249,386 external-priority patent/US6048902A/en
Application filed by MARK G LEBWOHL filed Critical MARK G LEBWOHL
Publication of AU2877800A publication Critical patent/AU2877800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU28778/00A 1999-02-12 2000-02-10 Short contact treatment of psoriasis with topical retinoids Abandoned AU2877800A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24938799A 1999-02-12 1999-02-12
US09249386 1999-02-12
US09249387 1999-02-12
US09/249,386 US6048902A (en) 1999-02-12 1999-02-12 Short contact treatment of psoriasis with topical retinoids
PCT/US2000/003457 WO2000047211A1 (en) 1999-02-12 2000-02-10 Short contact treatment of psoriasis with topical retinoids

Publications (1)

Publication Number Publication Date
AU2877800A true AU2877800A (en) 2000-08-29

Family

ID=26940026

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28778/00A Abandoned AU2877800A (en) 1999-02-12 2000-02-10 Short contact treatment of psoriasis with topical retinoids

Country Status (2)

Country Link
AU (1) AU2877800A (en)
WO (1) WO2000047211A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
AU2016279801B2 (en) * 2015-06-18 2021-09-09 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis
US20190133943A1 (en) * 2015-06-18 2019-05-09 Valeant Pharmaceuticals North America Topical compositions and methods for treating skin diseases
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516793A (en) * 1993-04-26 1996-05-14 Avon Products, Inc. Use of ascorbic acid to reduce irritation of topically applied active ingredients
US5650279A (en) * 1995-01-27 1997-07-22 Allergan, Inc. Gene sequence induced in skin by retinoids
US5719195A (en) * 1995-05-05 1998-02-17 4 Thought Technologies Treatment of psoriasis with 11-cis-retinoic acid

Also Published As

Publication number Publication date
WO2000047211A1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
PT3146969T (en) Ointment for the topical treatment of psoriasis
AU7859800A (en) Topical nasal treatment
AU2002360195A1 (en) Phototherapy for psoriasis and other skin disorders
AU7062400A (en) Topical use of kappa opioid agonists to treat otic pain
AU2754501A (en) Treatment of acne using lipoic acid
AU5455200A (en) The use of encapsulated acid in acid fracturing treatments
AU5087199A (en) Method of treating topical ailments
AUPQ877300A0 (en) Topical treatment of skin
AU1784301A (en) Topical skin composition
AU1773600A (en) Topical treatment of skin disease
AUPR074500A0 (en) Treatment of t cell disorders
GB9918760D0 (en) Topical treatment
AU2512501A (en) Use of trimebutine for treating pain
AU2001290961A1 (en) Method for topical treatment of anthralin-responsive dermatological disorders
AU3082401A (en) Therapy of psoriasis
AU5056099A (en) Compounds for use in the treatment of inflammation
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU9045298A (en) Topical application of opioids for treatment of acne and other inflammatory conditions
AU1853400A (en) Topical anesthesia of the urinary bladder
AU2877800A (en) Short contact treatment of psoriasis with topical retinoids
AUPN892496A0 (en) Acne treatment
AU1876797A (en) Topical formulations for the treatment of nail psoriasis
AU7106300A (en) Treatment of skin disorders
AU2001241630A1 (en) Treatment of inflammation with p20
AU5260400A (en) Collector-up rf power transistor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase